BIAF bioAffinity Technologies, Inc. - Common Stock
NASDAQ · Biotechnology close Oct 2, 2026BIAF Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
BIAF Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| Aug. 24, 2026 | 1-for-15 | Reverse |
| Sept. 19, 2025 | 1-for-30 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| Sept. 30, 2025 | $-71.10 | $-41.31 | -72.1% | |
| June 30, 2025 | $-76.50 | $-45.90 | -66.7% | |
| March 31, 2025 | $-72.00 | $-73.44 | 2.0% | |
| Dec. 31, 2024 | $-94.50 | $-64.26 | -47.1% |
Institutional owners (13F) 20 filers · $762K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 10 (+2 vs prior Q) | 4 (+1 vs prior Q) | 4 (+3 vs prior Q) | 1 (-1 vs prior Q) | +564K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | $296,905 | 365,647 | 38.96% | Shares |
| J. Safra Sarasin Holding AG | $164,010 | 42,600 | 21.52% | Shares |
| BlackRock, Inc. | $80,207 | 98,777 | 10.53% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $45,101 | 55,543 | 5.92% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $41,384 | 50,967 | 5.43% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $25,230 | 31,071 | 3.31% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $21,818 | 26,870 | 2.86% | Shares |
| JANE STREET GROUP, LLC | $21,748 | 26,784 | 2.85% | Shares |
| STATE STREET CORP | $19,558 | 24,086 | 2.57% | Shares |
| Sheaff Brock Investment Advisors, LLC | $13,971 | 53,734 | 1.83% | Shares |
| NORTHERN TRUST CORP | $13,599 | 16,748 | 1.78% | Shares |
| Allworth Financial LP | $8,120 | 10,000 | 1.07% | Shares |
| Tower Research Capital LLC (TRC) | $5,263 | 6,482 | 0.69% | Shares |
| UBS Group AG | $3,414 | 4,204 | 0.45% | Shares |
| ROYAL BANK OF CANADA | $1,000 | 931 | 0.13% | Shares |
| IFP Advisors, Inc | $676 | 833 | 0.09% | Shares |
| HRT FINANCIAL LP | $16 | 20,834 | 0.00% | Shares |
| Virtu Financial LLC | $9 | 11,113 | 0.00% | Shares |
| MORGAN STANLEY | $2 | 3 | 0.00% | Shares |
| EMC Capital Management | $1 | 2,001 | 0.00% | Shares |
Company insiders 14 insiders · 7 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Maria Zannes | President & CEO | Jan. 10, 2025 A | 280,359 | 0 | 0 | $0 |
| James Michael Edwards | VP and CFO | Jan. 10, 2025 A | 120,128 | 0 | 0 | $0 |
| Dougherty Michael Philip | Chief Financial Officer | Jan. 31, 2024 A | 84,203 | 0 | 0 | $0 |
| Xavier Trinidad Reveles | Chief Operating Officer | Jan. 10, 2025 A | 41,943 | 0 | 0 | $0 |
| Timothy P Zannes | Secretary, EVP, Gen. Counsel | Jan. 10, 2025 A | 54,765 | 0 | 0 | $0 |
| Steven Girgenti | Executive Chairman | Jan. 10, 2025 A | 1,080,062 | 0 | 0 | $0 |
| Vivienne I Rebel | Chief Sci. & Med. Officer, EVP | Jan. 31, 2024 A | 46,228 | 0 | 0 | $0 |
| Jamie Platt | Director | July 1, 2024 A | 54,748 | 0 | 0 | $0 |
| Roby Joyce | Director | July 1, 2024 A | 66,615 | 0 | 0 | $0 |
| Robert A. Anderson | Director | July 1, 2024 A | 163,936 | 0 | 0 | $0 |
| Stuart Diamond | Director | July 1, 2024 A | 99,088 | 0 | 0 | $0 |
| Peter S Knight | Director | July 1, 2024 A | 117,455 | 0 | 0 | $0 |
| Mohsin Y Meghji | Director | Oct. 1, 2023 A | 109,737 | 0 | 0 | $0 |
| Nathan M Perlmutter | 10% owner | July 20, 2022 A | 327,909 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 55,543 SH | Aug. 19, 2026 | Daily |
BIAF Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.